Inovotion Sas
INOVOTION is a Contract Research Laboratory implementing a unique approach to in vivo evaluation for anticancer drug discovery. Our cutting-edge proprietary technology provides early analysis of your compounds before the classical preclinical stage. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process and significantly reduces its costs. INOVOTION assays evaluate the EFFICACY and TOXICITY of your anticancer treatments and VALIDATE their TARGET. Our unique technology is based on new chick egg assays. INOVOTION’s fast, sensitive, reliable and affordable in vivo assays will save you money and give you a clear competitive advantage. After hundreds of successful studies realized for chemists and pharmaceutical companies, we decided to offer our technology to drug discovery partners worldwide: academic laboratories, biotech and pharmaceutical companies.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
We help Chemists and Biologists developing new mol...
We help Chemists and Biologists developing new molecules get through the in vivo evaluation to the next step without going over budget. This very accessible technology allows rapid Go/No Go decisions.
History
INOVOTION activities started in 2014, based on a proprietary technology initially invented in 2009, and after 5 years of R&D and more than 150 studies. It’s a spin-off of Joseph Fourier University, in Grenoble, France.
INOVOTION’s technology was developed at the Institut for Advanced Biosciences (formely Institut Albert Bonniot), a cancer research center on the University Hospital campus – Grenoble Alpes University, by the creator of the company: Prof Jean Viallet.
In the beginning, the technology answered the needs of an academic laboratory and quickly found a great success in the labs and companies that tested it.
Mission & Vision
Our Mission
Because we know that one of your main preoccupations is to optimize your preclinical and discovery studies, INOVOTION has established a unique and cutting-edge in vivo technology.
As a Contract Research Organisation (CRO) that is dedicated to in vivo evaluation for drug discovery, particularly in oncology, INOVOTION is a sought-after partner for drug discovery pharmaceutical and biotech companies as well as academic labs all over the world.
Our main missions are to:
- Help you to find the best anticancer candidate treatment
- Detect the first in vivo toxicity effects of your candidate compounds
- Improve the productivity of your preclinical and discovery process by maximizing your lead optimization phase
- Accelerate the overall drug discovery process to answer unmet medical needs in oncology
Our Vision
Due to our flexibility, can-do spirit and human size, we can plan, set up and run a tailored experimental protocol for your specific projects.
For each of our clients, INOVOTION provides a personalized solution.
Our scientific team brings a wealth of knowledge in oncology, target validation and toxicity and a close collaboration with our clients to always get a successful outcome.
Your success is our success.
Overall lead optimization and preclinical phases are the most expensive phases of drug development, representing 1/4 of the total cost. At the same time, these steps have a poor predictivity: less than 5%. That’s why INOVOTION pays particular attention to standardize its studies (biological reagent and reference material used), to make relevant study design, data analysis and report all within a framework reproducible with standard operating procedure.